Paul A. Friedman, Director at Incyte, holds 841.27K shares in Madrigal Pharmaceuticals (Ticker: MDGL), holds 0.00 shares in Alexion Pharmaceuticals (Ticker: ALXN), holds 500.10K shares in Prelude Therapeutics (Ticker: PRLD).
What is the percentage of profitable transactions made by Paul A. Friedman?
The percentage of profitable transactions made by Paul A. Friedman is 53%.
What is the average return per transaction made by Paul A. Friedman?
The average return per transaction made by Paul A. Friedman is 1.00%.
What stocks does Paul A. Friedman hold?
Paul A. Friedman holds: INCY, ALXN, PRLD, VSTM, MDGL, AUXL, DRTX, DARE stocks.
What was Paul A. Friedman’s latest transaction?
Paul A. Friedman latest transaction was an Uninformative Sell of $6.47M.
What was Paul A. Friedman's most profitable transaction?
Paul A. Friedman’s most profitable transaction was an Informative Sell of MDGL stock on June 12, 2018. The return on the trade was 57.30%.
What is Paul A. Friedman's role in Incyte?
Paul A. Friedman's role in Incyte is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.